Suggestions
Surendra Chikara
Founder & CEO at Bione
Professional Background
Surendra Chikara is a visionary leader in the field of genomics and microbiome testing, dedicated to humanizing direct-to-consumer health solutions. With significant experience in managing operations and driving business growth, Surendra has established himself as a formidable presence in the biotechnology sector. His entrepreneurial spirit led him to become the Founder and CEO of Bione, an innovative venture that aims to make advanced genetic insights accessible to consumers, ultimately promoting better health and lifestyle choices.
Previously, Surendra held pivotal roles in prominent organizations within the genomics industry. As the Vice President of Operations at MEDGENOME, he successfully led initiatives to enhance operational excellence and delivered substantial contributions to the company's growth in the genomics market. His leadership skills shone during his tenure as the Executive Director at Eurofins Clinical Genetics India Pvt Ltd and Eurofins Genomics India Pvt Ltd, where he oversaw strategic planning and operational management to align with overarching business goals.
Surendra's career also includes influential roles as Director and Chief Scientific Officer at Xcelris Labs Ltd, where his expertise facilitated advances in genetic research and product development. Earlier in his career, he served as General Manager of R&D at Magene Lifesciences Pvt Ltd and as a Scientist at Zydus Cadila, where he honed his research skills and acquired comprehensive knowledge of the biotech landscape.
Education and Achievements
Surendra Chikara's academic journey began with a Bachelor of Science in Biosciences from Jamia Millia Islamia, followed by a Master of Science in Biotechnology from Madurai Kamaraj University. He further pursued advanced studies, earning a Ph.D. in Molecular Microbiology from Osmania University. His educational foundation has provided him with a robust understanding of the molecular mechanisms underpinning health and disease, positioning him well to lead innovative approaches in genomics.
His expertise in building operational excellence is evident in his impressive record of using Key Performance Indicators (KPIs) to track sample inputs, run plans, and customer complaints, among other vital metrics. Surendra has demonstrated an aptitude for reviewing competitor analysis and crafting effective marketing strategies, empowering teams to implement plans that drive success.
In his roles, Surendra has focused on fostering relationships with key opinion leaders and institutional accounts to bolster brand reliability and quality. His strategic approach not only enhances customer engagement but also supports the profitable growth of the business. Surendra also plays an essential role in analyzing market demands for new products and business vertical developments, ensuring the successful launch of technologies developed through rigorous verifications and validations.
Achievements
Surendra's leadership has resulted in year-over-year profitability and value creation for shareholders at the organizations he has influenced. His commitment to operational excellence, coupled with an unwavering focus on clarity of expectations for his teams, fosters an environment where innovation can thrive. Surendra has significantly impacted the field of genomics and microbiome testing, setting the standard for quality and efficiency in direct-to-consumer settings.
His multifaceted skill set encompassing P&L management, budgeting, and strategic planning demonstrates his capability to align organizational goals with actionable business strategies effectively. Surendra is well-regarded for his ability to simplify complex processes, enabling his teams to achieve collective objectives that contribute to the overarching success of their enterprises. With a clear vision and commitment to continuous improvement, he continues to lead in a field that is rapidly evolving, ensuring that consumers have access to the highest quality genomic insights for better health outcomes.